Press release

Xcovery Partners with EVERSANA to Commercialize Lung Cancer Drug Ensacove in the U.S.

MIAMI and CHICAGO, April 27, 2026 /PRNewswire/ — Xcovery Holdings, Inc., (Xcovery) an evidence-based, innovation-driven pharmaceutical company, today announced an…

Read More »

Christopher Griffith Joins NEXA Lending to Expand Industry Impact and Elevate Service for Veteran Borrowers

MESA, Ariz., April 27, 2026 /PRNewswire/ — NEXA Lending, the nation’s largest mortgage broker in US history, today announced that…

Read More »

Reallusion Redefines Digital Double Creation with the Launch of Headshot 3 for Character Creator 5

SAN JOSE, Calif., April 27, 2026 /PRNewswire/ — Reallusion, the leader in 3D character creation software, announced the release of…

Read More »

Velo3D, Inc. Announces Pricing of $50 Million Underwritten Registered Direct Offering of Common Stock

FREMONT, Calif., April 27, 2026 /PRNewswire/ — Velo3D, Inc. (“Velo” or the “Company”), an industry leading metal additive manufacturing company,…

Read More »

Vision Marine Technologies Secures Conditional TSX Venture Exchange Listing Approval, Expanding Capital Markets Access for Its Marine Technology Platform

Capital Markets Strategy / Technology Platform Expansion BOISBRIAND, QC, April 27, 2026 /PRNewswire/ — Vision Marine Technologies Inc. (NASDAQ: VMAR) (“Vision…

Read More »

AZIO AI Corporation Expands Supplier Ecosystem, Secures Authorized Partnership with Giga Computing to Enhance Scalable AI Infrastructure Strategy

Partnership with GIGABYTE’s Enterprise Division Adds Specialized NVIDIA HGX Platform Capabilities and Liquid Cooling Expertise, Complementing Existing Supplier Relationships for…

Read More »

ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026

LAUSANNE, Switzerland, April 27, 2026 /PRNewswire/ — ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field…

Read More »

BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET

SAN RAFAEL, Calif., April 27, 2026 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and…

Read More »